Literature DB >> 30603892

Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2018. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Wael A AlJaroudi1, Fadi G Hage2,3.   

Abstract

In this review, we summarize key articles that have been published in the Journal of Nuclear Cardiology in 2018 pertaining to nuclear cardiology with advanced multi-modality and hybrid imaging including positron emission tomography, cardiac-computed tomography, and magnetic resonance. In an upcoming review, we will summarize key articles that relate to the progress made in the field of single-photon emission computed tomography. We hope that these sister reviews will be useful to the reader to navigate the literature in our field.

Keywords:  CAD; amyloid heart disease; heart Failure; inflammation; metabolic; sarcoid heart disease

Year:  2019        PMID: 30603892     DOI: 10.1007/s12350-018-01558-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  84 in total

1.  Coronary calcium scoring of CT attenuation correction scans: Automatic, manual, or visual?

Authors:  Shifali Dumeer; Andrew J Einstein
Journal:  J Nucl Cardiol       Date:  2017-07-24       Impact factor: 5.952

2.  Absolute myocardial blood flow vs relative myocardial perfusion: Which one is better?

Authors:  Tali Sharir; Gil Kovalski
Journal:  J Nucl Cardiol       Date:  2017-05-05       Impact factor: 5.952

3.  Hybrid PET/CT and PET/MRI imaging of vulnerable coronary plaque and myocardial scar tissue in acute myocardial infarction.

Authors:  Stephanie Marchesseau; Aruni Seneviratna; A Therese Sjöholm; Daphne Liang Qin; Jamie X M Ho; Derek J Hausenloy; David W Townsend; A Mark Richards; John J Totman; Mark Y Y Chan
Journal:  J Nucl Cardiol       Date:  2017-05-12       Impact factor: 5.952

4.  "Heart failure, whole-body insulin resistance and myocardial insulin resistance: An intriguing puzzle".

Authors:  Paola Gargiulo; Pasquale Perrone-Filardi
Journal:  J Nucl Cardiol       Date:  2016-08-02       Impact factor: 5.952

5.  Effect of prolonged fasting and low molecular weight heparin or warfarin therapies on 2-deoxy-2-[18F]-fluoro-D-glucose PET cardiac uptake.

Authors:  Assuero Giorgetti; Gavino Marras; Dario Genovesi; Elena Filidei; Antonio Bottoni; Maurizio Mangione; Michele Emdin; Paolo Marzullo
Journal:  J Nucl Cardiol       Date:  2017-02-03       Impact factor: 5.952

6.  PET/CTA detection of muscle inflammation related to cholesterol crystal emboli without arterial obstruction.

Authors:  M Hassan Pervaiz; Sridevi Durga; Abed Janoudi; Kevin Berger; George S Abela
Journal:  J Nucl Cardiol       Date:  2017-02-21       Impact factor: 5.952

7.  Impact of pharmacological stress agent on patient motion during rubidium-82 myocardial perfusion PET/CT.

Authors:  Matthew J Memmott; Christine M Tonge; Kimberley J Saint; Parthiban Arumugam
Journal:  J Nucl Cardiol       Date:  2017-01-04       Impact factor: 5.952

8.  Dual-time-point FDG PET/CT imaging in prosthetic heart valve endocarditis.

Authors:  A M Scholtens; L E Swart; H J Verberne; R P J Budde; M G E H Lam
Journal:  J Nucl Cardiol       Date:  2017-05-04       Impact factor: 5.952

9.  Partial volume correction for improved PET quantification in 18F-NaF imaging of atherosclerotic plaques.

Authors:  Jacobo Cal-Gonzalez; Xiang Li; Daniel Heber; Ivo Rausch; Stephen C Moore; Klaus Schäfers; Marcus Hacker; Thomas Beyer
Journal:  J Nucl Cardiol       Date:  2017-02-07       Impact factor: 5.952

Review 10.  PET imaging of inflammation in atherosclerosis.

Authors:  Jason M Tarkin; Francis R Joshi; James H F Rudd
Journal:  Nat Rev Cardiol       Date:  2014-06-10       Impact factor: 32.419

View more
  1 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.